Elefant Dov
- SEC CIK
- 0001326487
In the past year, 1 open-market purchase filing worth $50.0K and no sales.
Current role at each company
- FEMY Femasys IncChief Financial Officeras of Aug 11, 2026
- CLRB Cellectar Biosciences, Inc.Chief Financial Officeras of Jan 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $50.0K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$50.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Elefant Dov as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FEMY Femasys Inc
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 (view filing)8:37 PM ET | Aug 7 | 4 days | Elefant DovChief Financial Officer | PPurchase | +15.6K | $3.20 | +$50.0K | New position15.6K after |